levonorgestrel Articles
Good 1st-half sales and profits at Schering AG
28 July 2000
New emergency contraception OKed in the UK
16 December 1999
Wyeth-Ayerst launches OC in Japan
9 September 1999
Wal-Mart won't sell Preven contraceptive
19 May 1999
Norplant trial collapses
11 February 1999
Europe/US sales offset Asian crisis at Schering
9 February 1999
Phase III for emergency contraceptive
21 December 1998
First Emergency Contraceptive Cleared In USA
10 September 1998
Yuzpe Topped By Progestin Morning-After Pill
11 August 1998
Berlex' Levlite Approved In USA
16 July 1998
Schering AG: No Plans To Take PC4 From POM To P
17 June 1998
FDA Clears Wyeth-Ayerst's Alesse
7 April 1997
Schering AG Launches New HRT Patch In UK
17 March 1997
CPMP Position On 3rd Generation Contraceptives
3 February 1997
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
Solid 3rd Qtr Growth For Large Pharma Cos
31 October 1994
AHP Bid For Cyanamid Will Broaden Product Range
15 August 1994
INTRA-UTERINE DEVICE COULD BE A BREAKTHROUGH
4 April 1994
NORPLANT LAUNCHED IN UK
25 October 1993
AMERICAN HOME: FINALLY A PHARMA COMPANY
7 December 1992
FRANCE LOWERS ORAL CONTRACEPTIVE PRICES
13 January 1992
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
